HKEX:6978 stock news
This page provides real-time market news, earnings updates, and company announcements related to Immunotech Biopharm Ltd (HKEX:6978).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-05 08:10 HKT
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
Finviz2026-02-12 21:39:08
AIM ImmunoTech Announces Planned Milestones in the Ongoing Phase 2 Trial of Ampligen and AstraZeneca's Durvalumab in the Treatment of Metastatic Pancreatic Cancer
Finviz2026-02-23 13:57:57
AIM ImmunoTech Announces Extension of Subscription Period of its Previously Announced Rights Offering to March 3, 2026
Finviz2026-02-25 14:03:11
AIM ImmunoTech Inc. recently announced that it will extend the exercise period for shareholder subscription rights in its previously announced stock offering plan.
老虎证券2026-02-25 14:25:16
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
Finviz2026-02-27 14:04:16
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Finviz2026-03-02 14:03:11
AIM ImmunoTech Inc. has signed an agreement to plan a proposed Phase III clinical trial of its core candidate drug Ampligen for the treatment of advanced pancreatic cancer.
老虎证券2026-03-02 14:13:58
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
Finviz2026-03-04 14:03:47
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
Finviz2026-03-04 14:03:47
AIM ImmunoTech Announces Closing of its Rights Offering
Finviz2026-03-07 00:03:53
Patent Approval Drives Stock Price Surge: AIM ImmunoTech Inc. (AIM) shares soared 88% in pre-market trading today, reaching $1.34
老虎证券2026-03-18 13:36:10
AIM Stock Jumps 77% With No Clear Catalyst
101 finance2026-03-18 15:06:59
Theravance Biopharma’s $70M Restructuring Cash Flow Catalyst Now Outpaces Missed $75M Milestone Hopes
101 finance2026-03-18 14:34:26
X’s Reliability Crisis Sparks Behavioral Overreaction—Is the Market Overestimating the Risk?
101 finance2026-03-18 15:52:02
Noon Market Summary: Crude Oil Rises 2.2% as Tensions Escalate, Tech Giants Drag S&P 500 Down 0.57%
101 finance2026-03-18 16:15:40
AIM ImmunoTech Stock Surges 43.66% on Landmark Japanese Patent for Pancreatic Cancer Therapy Ranks 489th in $240M Trading Volume
101 finance2026-03-19 01:12:53
Aimco’s Chicago Sale Fuels $0.85–$0.95 Per Share Liquidating Payout Countdown
101 finance2026-03-30 23:37:02
AIM ImmunoTech Reminds Stockholders of March 3, 2026 Expiration Date and Updates Terms of Previously Announced Rights Offering
Finviz2026-02-27 14:04:16
AIM ImmunoTech Signs Agreement for Planning of a Proposed Phase 3 Clinical Trial of Ampligen in the Treatment of Late-Stage Pancreatic Cancer
Finviz2026-03-02 14:03:11
AIM ImmunoTech Inc. has signed an agreement to plan a proposed Phase III clinical trial of its core candidate drug Ampligen for the treatment of advanced pancreatic cancer.
老虎证券2026-03-02 14:13:58
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
Finviz2026-03-04 14:03:47
AIM ImmunoTech Announces Expiration and Preliminary Results of its Rights Offering for Aggregate Gross Proceeds of $1.8 Million
Finviz2026-03-04 14:03:47
AIM ImmunoTech Announces Closing of its Rights Offering
Finviz2026-03-07 00:03:53
Patent Approval Drives Stock Price Surge: AIM ImmunoTech Inc. (AIM) shares soared 88% in pre-market trading today, reaching $1.34
老虎证券2026-03-18 13:36:10
AIM Stock Jumps 77% With No Clear Catalyst
101 finance2026-03-18 15:06:59
Theravance Biopharma’s $70M Restructuring Cash Flow Catalyst Now Outpaces Missed $75M Milestone Hopes
101 finance2026-03-18 14:34:26
X’s Reliability Crisis Sparks Behavioral Overreaction—Is the Market Overestimating the Risk?
101 finance2026-03-18 15:52:02
Noon Market Summary: Crude Oil Rises 2.2% as Tensions Escalate, Tech Giants Drag S&P 500 Down 0.57%
101 finance2026-03-18 16:15:40
AIM ImmunoTech Stock Surges 43.66% on Landmark Japanese Patent for Pancreatic Cancer Therapy Ranks 489th in $240M Trading Volume
101 finance2026-03-19 01:12:53
Aimco’s Chicago Sale Fuels $0.85–$0.95 Per Share Liquidating Payout Countdown
101 finance2026-03-30 23:37:02
HKEX:6978 stock price change
On the last trading day, HKEX:6978 stock closed at 2.72 HKD, with a price change of -0.73% for the day.
Trade stock perpsHKEX:6978 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more